New study aims to cut pneumonia risk in HIV patients with smart medication checks

NCT ID NCT07507435

Not yet recruiting Disease control Sponsor: Seattle Institute for Biomedical and Clinical Research Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study tests whether a pharmacist-led electronic consultation can improve lung health for people with HIV who smoke or use certain medications that raise pneumonia risk. Pharmacists will review records and suggest changes like smoking cessation aids, vaccines, or stopping unnecessary inhalers or acid reflux drugs. The goal is to see if these recommendations are followed and if they lead to better health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease pneumonia Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INHALED CORTICOSTEROID PNEUMONIA PROTON PUMP INHIBITOR SMOKING CESSATION

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Boise VA Medical Center

Boise, Idaho, 83702, United States
Minneapolis VA Health Care System

Minneapolis, Minnesota, 55417, United States
VA Puget Sound Health Care System

Seattle, Washington, 98108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.